Clinical Trial Update: Tenofovir Disoproxil Fumarate to Treat Pediatric HIV [Phase 1]

View source ↗

Summary

This clinical trial update describes a Phase 1 pediatric HIV study evaluating Tenofovir Disoproxil Fumarate, noting that the trial status is completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• HIV Infection

Drugs mentioned

• TENOFOVIR DISOPROXIL FUMARATE (tenofovir disoproxil fumarate)

Snippet

Sponsor: National Cancer Institute (NCI) | Conditions: HIV Infection | Phase 1 | Status: COMPLETED